Conatus Pharmaceuticals Inc. | Termination Agreements | Business Contracts

Settlement, Release and Termination Agreement, dated April 5, 2019, by and among Histogen Inc., PUR Biologics, LLC, Wylde, LLC, Christopher Wiggins and Ryan Fernan (Filed With SEC on February 7, 2020)

Conversion, Termination and Release Agreement, dated August 10, 2016, by and among Histogen Inc., Jonathan Jackson, Lordship Ventures LLC and Lordship Ventures Histogen Holdings... (Filed With SEC on February 7, 2020)

Termination of Stockholder Agreements, dated January 28, 2020, by and among Histogen Inc., Lordship Ventures Histogen Holdings LLC, Pineworld Capital Limited, Gail K. Naughton,... (Filed With SEC on February 7, 2020)

Conatus Pharmaceuticals Inc. (84) | Termination Agreements (3)